Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
- PMID: 33147540
- DOI: 10.1016/j.jneuroim.2020.577431
Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
Abstract
This study aimed to determine the seasonal impact on the clinical onset of inflammatory neurological diseases of the central nervous system by analyzing the onset month with information on clinical manifestations in Japanese patients. As a result, patients with anti-aquaporin-4 antibodies (AQP4-IgG)-positive neuromyelitis optica spectrum disorders (NMOSD) showed spring-summer predominance of the clinical onset. Conversely, patients with anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease showed autumn-winter predominance of the clinical onset. Both seasonal variations were irrespective of the clinical manifestation. Environmental factors with seasonal variation influence the development of neurological conditions related to AQP4-IgG and MOG-IgG.
Keywords: Aquapotin-4; Attacks; Myelin-oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorders; Seasonal distribution.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31. J Neurol Sci. 2017. PMID: 28991690
-
Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.Rev Neurol (Paris). 2018 Jun;174(6):458-470. doi: 10.1016/j.neurol.2018.02.084. Rev Neurol (Paris). 2018. PMID: 29685427 Review.
-
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.J Neuroinflammation. 2016 Sep 26;13(1):279. doi: 10.1186/s12974-016-0717-1. J Neuroinflammation. 2016. PMID: 27788675 Free PMC article.
-
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857. JAMA Neurol. 2014. PMID: 24425068
-
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.Rev Neurol (Paris). 2018 Dec;174(10):675-679. doi: 10.1016/j.neurol.2018.01.378. Epub 2018 Oct 4. Rev Neurol (Paris). 2018. PMID: 30293882 Review.
Cited by
-
Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series.Brain Behav. 2024 May;14(5):e3534. doi: 10.1002/brb3.3534. Brain Behav. 2024. PMID: 38702897 Free PMC article.
-
Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder.Front Genet. 2021 Jul 21;12:690537. doi: 10.3389/fgene.2021.690537. eCollection 2021. Front Genet. 2021. PMID: 34367251 Free PMC article.
-
Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide.Front Neurol. 2023 Sep 15;14:1260358. doi: 10.3389/fneur.2023.1260358. eCollection 2023. Front Neurol. 2023. PMID: 37789888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials